Tag: Tuberous Sclerosis Complex

Jazz Pharmaceuticals to acquire Epidiolex developer GW Pharmaceuticals for $7.2bn

pharmanewsdaily- February 3, 2021

Irish biopharma company Jazz Pharmaceuticals has agreed to acquire British pharma company GW Pharmaceuticals in a cash-cum-stock deal worth $7.2 billion. Upon closing of the ... Read More